FDA official overseeing food policy and response to resign in wake of baby formula shortage
Frank Yiannas’ resignation comes weeks after an expert panel issued a scathing report on the FDA’s foods program.
DOT is probing whether Southwest’s schedules were ‘unrealistic’ during holiday meltdown
Southwest canceled more than 16,000 flights over the holidays.
Elon Musk’s Twitter faces censorship allegations in India free speech battle
Twitter appears to have restricted several tweets sharing media critical of India’s Prime Minister Narendra Modi.
Snapchat’s role in fentanyl crisis probed during House roundtable: ‘It’s a Snap-specific problem’
Snap-owned Snapchat, and its role in the fentanyl crisis, was the focus of a House roundtable hosted by the Energy and Commerce Committee on Wednesday.
AT&T shares jump as subscriber growth tops analyst expectations
CEO John Stankey dismissed the idea that the phone carrier industry is in a pricing war.
Tesla reports record revenue and beats on earnings
Electric vehicle maker Tesla reported earnings after the bell. Here are the results.
Oliver Stone’s new film puts nuclear energy in the spotlight. These stocks are ready to hop on the trend
For investors, the film adds to growing interest in nuclear power as a fossil fuel alternative beyond renewables.
Why Live Nation and Ticketmaster dominate the live entertainment industry
Consumers are calling for the Live Nation and Ticketmaster monopoly to end. Here’s how they became the dominant force in the live entertainment business.
Abortion pill maker GenBioPro sues West Virginia, argues FDA rules preempt state ban
GenBioPro argues that FDA regulations on the abortion pill preempt West Virginia’s state law that basically bans the medication.
